nGeno
nGeno invests in SmartPatch, a wearable IoT device (BLE) monitoring vital signs (temp, HR, SpO2, pH, hydration) via medical-grade silicon, active/passive modes. Focus: healthtech.
Funding Stage: Pre-Seed / Seed
Investor type: VC Firm
Investment Areas: Consumer Electronics, Internet of Things, Personal Health, Social
Country: Poland
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.